BlueLinx Holdings and JELD-WEN Holding both operate within the U.S. building-products ecosystem, yet they sit at different points in the value chain. BlueLinx functions as a wholesale distributor of structural and specialty building materials, while JELD-WEN manufactures doors, windows, and related products on a global scale. Comparing the two provides a clear view of how distribution and manufacturing models are faring amid softer housing and construction demand. This analysis is particularly relevant for investors assessing relative performance, margin resilience, and balance-sheet strength in companies that share end markets but differ significantly in their financial profiles and risk exposures.
BXC, or BlueLinx Holdings Inc., distributes residential and commercial building products across the United States, with a deliberate shift toward higher-margin specialty items such as engineered wood, siding, millwork, and outdoor living. Specialty products have recently made up about 70% of net sales and more than 80% of gross profit. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
BlueLinx has shown relatively stable top-line results despite the difficult housing environment. Full-year fiscal 2025 net sales remained essentially flat near $3.0 billion, though gross margin narrowed due to price deflation in structural products. The company posted a modest quarterly net loss in its latest period, partly from higher operating expenses and acquisition costs, but it maintained positive operating cash flow through careful inventory management. Recent moves include acquiring Disdero, a specialty distributor, and investing in digital tools and artificial-intelligence capabilities to boost efficiency. With a solid balance sheet and an active share-repurchase program, BlueLinx has kept a steadier financial footing than many manufacturing peers.
JELD, or JELD-WEN Holding, Inc., designs and manufactures wood, metal, and composite doors and windows for residential and commercial customers in North America and Europe. As a manufacturer, JELD-WEN carries significant fixed-cost infrastructure, which magnifies the effect of volume drops on its profitability.
Recent results have been notably weaker. Net revenues fell by a double-digit percentage in the most recent quarter, mainly from lower volumes and softer demand, especially in North America. The company has continued to report net losses, and its full-year figures included large non-cash goodwill impairment charges plus a valuation expense on U.S. tax attributes. Management has implemented workforce reductions and targeted cost measures, describing these as initial steps in a turnaround. Still, equity value has dropped sharply, leverage has increased, and shareholders’ equity has turned negative. A court-ordered divestiture of its Towanda facility has added further challenges, leaving JELD-WEN in a more strained position overall.
The core difference lies in business models. BlueLinx uses an asset-light distribution approach that lets it adjust inventory and working capital swiftly when demand changes. JELD-WEN’s manufacturing setup carries higher fixed costs, making earnings more sensitive to volume fluctuations. This shows up clearly in results: BlueLinx has kept revenue roughly flat and preserved positive cash flow, while JELD-WEN has absorbed steep revenue declines and losses.
Growth paths also differ. BlueLinx is emphasizing specialty products, multifamily and builder channels, and technology-driven efficiencies aimed at margin improvement. JELD-WEN, meanwhile, is centered on cost cuts, restructuring, and demand stabilization—a more defensive stance. On the risk side, JELD-WEN’s negative equity, higher leverage, and goodwill impairments point to substantially greater financial risk than BlueLinx’s more conservative balance sheet. Both face similar sector exposure, but they capitalize on it differently, and market reaction has reflected that: BlueLinx has maintained a steadier valuation, whereas JELD-WEN’s share price has fallen sharply and now trades as a distressed equity.
Based on factors such as trend consistency, balance-sheet stability, cash-flow generation, and catalysts, Tickeron’s AI framework currently favors BXC over JELD. BlueLinx shows a more stable financial path, a more defensive model, and a clearer route to margin recovery via its specialty mix. JELD-WEN may offer some turnaround potential, but it carries higher uncertainty due to ongoing losses, impairments, negative equity, and elevated leverage. The verdict is probabilistic: the evidence points toward BlueLinx as the more stable choice of the two, though outcomes are never guaranteed and both remain tied to housing-market conditions.
In my ongoing research, I frequently review Tickeron’s Trending AI Robots to identify automated strategies that align with current market conditions. These bots cover thousands of tickers with varied styles, timeframes, and performance data, helping narrow focus to approaches that appear most relevant right now. This step adds useful quantitative perspective when weighing names like these two.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BXC declined for three days, in 256 of 330 cases, the price declined further within the following month. The odds of a continued downward trend are 78%.
The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BXC as a result. In 65 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for BXC turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 36 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.
BXC moved below its 50-day moving average on November 03, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BXC crossed bearishly below the 50-day moving average on November 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 71%.
The Aroon Indicator for BXC entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for BXC's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +5.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where BXC advanced for three days, in 231 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
BXC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.767) is normal, around the industry mean (4.173). BXC's P/E Ratio (-275.545) is considerably lower than the industry average of (2.286). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (2.538). Dividend Yield (0.073) settles around the average of (0.452) among similar stocks. P/S Ratio (0.198) is also within normal values, averaging (3.013).
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. BXC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 92 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BXC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 66, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Operates as a holding company and distributes building products
Industry ElectronicsDistributors